Company Mabvax Therapeutics Holdings Inc Other OTC
Equities
US55414P1084
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2020 | MabVax Therapeutics Holdings, Inc. Went Out of Business | CI |
2020 | Second Amended Liquidation Plan & Disclosure Statment Approved for MabVax Therapeutics Holdings, Inc. | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 72 | - | |
Chief Tech/Sci/R&D Officer | 81 | 07/07/14 | |
Paul W. Maffuid
CTO | Chief Tech/Sci/R&D Officer | 68 | 07/07/14 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 81 | 07/07/14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 33,333 | 0 | 0 | 92.02 % |
Stock B | 0 | 44,104 | 0 | 0 | |
Stock C | 1 | 9,429,582 | 8,677,104 ( 92.02 %) | 0 |
Company contact information
MabVax Therapeutics Holdings, Inc.
559 Evans Mountain Road
72031, Clinton
+858-259-9405
Sector
1st Jan change | Capi. | |
---|---|---|
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+1.37% | 22.48B | |
-9.74% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B |
- Stock Market
- Equities
- MBVXQ Stock
- Stock
- Company Mabvax Therapeutics Holdings Inc